Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-122482
Filing Date
2024-11-06
Accepted
2024-11-06 17:24:36
Documents
2
Period of Report
2024-11-05

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1631
2 EX-24.1 abos-ex24_1.htm EX-24.1 11497
  Complete submission text file 0000950170-24-122482.txt   14586
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210 NEWTON MA 02465
Business Address
Schacterle Amy (Reporting) CIK: 0002042021 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40551 | Film No.: 241432297